Previous studies investigated the role of von Hippel–Lindau mutation, hypoxia-inducing factor (HIF), and vascular endothelial growth factor (VEGF) (3) however, limited ones investigated the role of other proangiogenic molecules such as Nestin and FLT1 in RCC. This evidence concerns the gene NES and renal cell carcinoma.